Literature DB >> 1800167

Cytokines in proliferative vitreoretinopathy.

G A Limb1, B C Little, A Meager, J A Ogilvie, R A Wolstencroft, W A Franks, A H Chignell, D C Dumonde.   

Abstract

This study determined the presence of interleukin 1 (IL-1), interleukin 6 (IL-6), tumour necrosis factor alpha (TNF alpha), tumour necrosis factor beta (TNF beta), interferon gamma (IFN gamma), transforming growth factor beta 2 (TGF beta 2) and fibroblast proliferation activity (FPA) in vitreous aspirates from eyes undergoing vitrectomy for the treatment of retinal detachment complicated by proliferative vitreoretinopathy (PVR) or uncomplicated retinal detachment (RD). Cadaveric vitreous from normal subjects were used as controls. The results showed that IL-1 and IL-6 predominated in vitreous from eyes with PVR or RD, and that concentrations of IL-6 greater than 20 pg/ml were more frequently found in PVR than in RD (p = 0.031) or control specimens (p = 0.006). Low levels of TNF alpha were observed in 4/18 eyes with PVR, 1/15 eyes with RD and 1/15 control vitreous, and small concentrations of TNF alpha were seen in 3/18 eyes with PVR, 1/15 eyes with RD and 2/15 control vitreous. IFN gamma was detected in 12/18 eyes with PVR, but only in 5/15 eyes with RD (p = 0.048) and 6/15 control specimens. TGF beta 2 was present in all vitreous samples at concentrations ranging from 100 to 4,500 pg/ml with no significant differences among the three groups. Control vitreous possessed the greatest FPA when compared with vitreous from eyes with PVR (p = 0.031) or RD (p = 0.048). These observations provide further evidence that cytokine-mediated pathways of inflammation are involved in the pathogenesis of PVR and point to the possible involvement of IL-1, IL-6 and IFN gamma in cellular interactions leading to chronicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800167     DOI: 10.1038/eye.1991.126

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  48 in total

1.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.

Authors:  A Ando; M Ueda; M Uyama; Y Masu; S Ito
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

3.  Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells.

Authors:  J Troger; S Sellemond; G Kieselbach; M Kralinger; E Schmid; B Teuchner; Q A Nguyen; E Schretter-Irschick; W Göttinger
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 4.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

5.  The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR).

Authors:  Khaled Nassar; Julia Lüke; Matthias Lüke; Mahmoud Kamal; Effat Abd El-Nabi; Mahmoud Soliman; Martin Rohrbach; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-07       Impact factor: 3.117

6.  Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

7.  Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.

Authors:  R H Y Asaria; C H Kon; C Bunce; C S Sethi; G A Limb; P T Khaw; G W Aylward; D G Charteris
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

8.  Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion.

Authors:  Chi-Ming Chan; Jheng-Hua Huang; Han-Sun Chiang; Wen-Bin Wu; Hsin-Huang Lin; Jing-Yin Hong; Chi-Feng Hung
Journal:  Mol Vis       Date:  2010-04-03       Impact factor: 2.367

9.  Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

Authors:  R G Williams; S Chang; M R Comaratta; G Simoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

10.  Proliferative vitreoretinopathy: an examination of the involvement of lymphocytes, adhesion molecules and HLA-DR antigens.

Authors:  G A Limb; W A Franks; K R Munasinghe; A H Chignell; D C Dumonde
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.